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Perspective
Uphill battle: The saga of hcg research that led to a paradigm shift

contain structurally similar CG and/or LH molecules,
but their functions may not necessarily be the same3-5.
It has been a mystery for decades why only humans
and subhuman primates have hCG, when they already
have a functionally similar LH6. The best guess is that
evolutionary and selection pressures may have led to
the CG appearance. These pressures could have been
that human and primate pregnancies might have faced
unusual hurdles during evolution and to overcome
them, sturdier, longer lasting and multifunctional
molecule such as CG, might have been required7,8. The
CG appearance required its receptors and signaling
systems and all three might have co-evolved. Different
hormone receptor systems share the same signaling
systems. This sharing might have been made possible
by an evolution of co-regulatory molecules, which
allowed for specificity, sensitivity and additional sites
of regulation.

Human chorionic gonadotropin (hCG), is a
heterodimeric glycoprotein, primarily produced and
secreted by placental syncytiotrophoblasts in large
quantities. Some normal and cancer tissues can also
secrete hCG in small quantities but it is short lived in
the circulation due to lower abundance of carbohydrate
moieties on the hCG molecules1. Placental hCG is a
collection of molecules differing in structure, function
and circulatory half-lives. The hCG is also present in
subhuman primates, but not in other animal species1.
It not only belongs to glycoprotein hormones family,
but also to the cystine knot growth factor family,
which consists of transforming growth factors-ß,
platelet derived growth factor and nerve growth factor.
Belonging to the same family implies that these diverse
set of molecules may have some common functional
features.
hCG is structurally and functionally similar to
luteinizing hormone (LH), secreted by gonadotropes
in anterior pituitary gland. Because there is only one
receptor, hCG and LH mimic each other’s functions2.
However, these functions differ quantitatively, which
primarily arise from the differences in their circulatory
half-lives. hCG has a longer circulatory half-life than
LH, due to abundance of carbohydrate residues. It is
theoretically possible however, that hCG and LH may
have distinct functions in select tissues and situations,
due to potential unique conformational changes
that each hormone can induce in the same receptor
molecules. The LH is present in circulation in a cyclical
manner during non-pregnancy and once pregnancy is
initiated, the cyclicity stops and the levels fall to baseline and remain there until menstrual cycles resume
after lactation.

The identification of hCG dates back more than 50
years. Most of that time, it was known for its actions to
rescue corpus luteum from regression in a fertile cycle.
Corpus luteum is needed for secretion of progesterone,
which maintains pregnancy. The progesterone secretion
progressively shifts from corpus luteum to placenta and
is completed by about the 9th week of pregnancy. This
completion obviates the need for the corpus luteum
for pregnancy continuation. However, both the corpus
luteum and hCG are maintained throughout pregnancy.
It does not make sense for cells to continue secreting
hCG, when it has no function during the remainder
of the pregnancy. The chances are that hCG has other
functions. Indeed, the research in the past 25 yr has
shed light on this possibility. It is now known that
many other tissues respond to hCG1,9-11 (Box).

Although hCG presence is restricted to humans
and subhuman primates, but LH is present in all
species. Unicellular organisms, fish and nematodes also

The hCG actions in these tissues is context,
tissue and cell type dependent9-11. The sum of all the
hCG actions during pregnancy can be summarized
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Box. Non gonadal tissue targets for hCG
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Oocyte
Early embryo
Human embryonic stem cells
Fallopian tubes
Uterus
Cervix
Placenta
Decidua

••
••
••
••
••

Foetal membranes
Several brain regions, including
pineal gland
Spinal cord
Neural retina
Adrenal cortex

••
••
••
••
••
••
••

Skin
Mammary glands
Bone
Adipose tissue
Urinary bladder
Target tissue vasculature
Umbilical cord

Source: Refs 1, 9-11

into five categories: those that favour pregnancy
initiation, pregnancy maintenance, safeguard foetus
from rejection, support foetal growth and development
and allow delivery when foetus is sufficiently mature
so it can survive outside the womb. The probable
evolutionary significance of hCG actions is to safeguard
pregnancy against all the odds during the evolution
of primates. This could also include providing a
relief from maladies that could potentially interfere
with the successful completion of pregnancy. These
maladies, for example, could be rheumatoid arthritis,
certain pathogen infections and other conditions which
threaten pregnancy continuation. In view of the above
discussion, it is easy to understand why hCG has such
broad regulatory roles in the body.
This leads to the next issue of whether the broad
regulatory roles of hCG are totally unexpected. The
answer is simply no. As it turns out that many other
hormones, for example, prolactin, follicle stimulating
hormone (FSH), gonadotropin releasing hormone,
oxytocin, relaxin, etc. have multiple sites of action
beyond their conventional targets and there is no
reason that hCG should be any different from these
other hormones. The multiple uses of hormones may
have been conserved because of the environment and
mode of life changes during the evolution of organisms.
Finally, multiple hormone uses could represent a
functional redundancy and efficiency.
The finding that hCG regulates multiple target
tissues, represents a paradigm shift. This paradigm
shift has offered likely explanations for many poorly
understood things about human pregnancy such as, why
breast cancer risk decreases in women who complete a
full term pregnancy before 20 yr of age, why pregnancy
ameliorates the symptoms of rheumatoid arthritis,
whether there is an hormonal basis for behavioural
changes and urinary tract symptoms seen during
pregnancy and why foetus is not often infected when

mother is HIV positive. There is also a pathological
relevance for the paradigm shift. For example,
gestational trophoblastic diseases, hyperemesis
gravidarum, several pregnancy complications, etc can
now be attributed to some of the facet of hCG actions.
Paradigm shift offered likely explanations for some
of the age related health issues, such as endometrial
cancer, osteoporosis, Alzheimer’s disease, etc.10,11.
The paradigm shift offered the novel therapeutic
options, such as treatment of miscarriages, preterm
birth, breast cancer, gynaecological infections, HIV/
AIDS and rheumatoid arthritis. These potential novel
therapies with hCG are inexpensive, non-toxic, have
minimal or no side effects and no harm is likely in case
of treatment failure.
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